𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of systemic sclerosis with recombinant interferon-γ. A phase I/II clinical trial

✍ Scribed by Bruce Freundlich; Sergio A. Jimenez; Virginia D. Steen; Thomas A. Medsger Jr.; Michelle Szkolnicki; Howard S. Jaffe

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
839 KB
Volume
35
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C with re
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels

A phase I clinical trial of immunotherap
A phase I clinical trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells : Monitoring the humoral immune response
✍ Zeinab Abdel-Wahab; Christina Weltz; Dina Hester; Nancy Pickett; Carol Vervaert; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

and then 18 million for the fifth and sixth injections. The humoral immune responses of the patients were assessed by enzyme-linked immunoadsorbent assay, radioimmunoassay, and radioimmunoprecipitation. ## RESULTS. Thirteen of the 20 patients completed the immunization protocol. Eight of these 13